• Search
  • Helpdesk
  • Sales contact

//White paper// eCOA vs COA: pros and cons

23 March 2017

Electronic tools allow the collection of data (electronic Clinical Outcomes Assessments [eCOA]) from patients, physicians, observers (mainly parents), and caregivers using smartphones, tablets, or the internet. Over recent years, due to numerous advantages, such tools are increasingly preferred to paper questionnaires for primary and/or secondary endpoint data collection in clinical and epidemiological studies. That’s the reason why the pros and cons of eCOA vs COA have to be considered.

The wide use of eCOAs in clinical trials has largely confirmed the theoretical advantages of electronic over paper questionnaires, including improved data quality and better confidence in these data. Here are the pros and cons regarding eCOA vs COA solutions.

By Olivier Chassany, Professor of PROs & Clinical Endpoints research at the University Paris-Diderot, France

TO READ THE WHITE PAPER, CLICK BELOW:

[tag url=”https://kayentis.com/wp-content/uploads/2017/03/kayentis_whitepaper_ecoa_vs_coa.pdf” event=”click dossier eCOA vs COA”]

Kayentis_White_Paper eCOA vs COA page1

Interested by the differences between eCOA and COA? Click here to see our infography regarding 7 lesser know advantages of eCOA over COA.

Follow us on social media
Subscribe to our newsletter
About the author
Meet us at the following events

SCOPE 2025

FEB 3-6 2025 • Orlando, USA
Booth #931 https://www.scopesummit.com/

OCT West Coast 2025

FEB 11-12 2025 • Burlingame,CA, USA
Booth #68 17th Annual Outsourcing in Clinical Trials West Coast 2025 - Arena International

ACDM 2025

MAR 2-4 2025 • Prague, Czech Republic
Booth #12 ACDM25 Prague 2-4 March

C-PATH 2025

APR 9-10 2025 • Rockville, Maryland, USA

OCT Europe 2025

APR 29-30 2025 • Barcelona, Spain
Booth #74 15th Annual Outsourcing in Clinical Trials Europe 2025 - Arena International